Visiongain has published a new report entitled Antisense Oligonucleotide (ASO) Therapeutics Market Report 2023-2033: Forecasts by Therapeutic Application.
iCo Therapeutics Inc. (OTCMKTS:ICOTF – Get Rating)’s stock price crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.31 and traded as high as $0.40. iCo Therapeutics shares last traded at $0.39, with a volume of 61,000 shares trading hands. iCo Therapeutics Price […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Toronto, Ontario (Newsfile Corp. - April 29, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change